French medical device company Mauna Kea Technologies has secured US Food and Drug Administration (FDA) 510(k) clearance for its confocal miniprobes.

With this clearance, confocal miniprobes can now be used with the near-infrared Cellvizio platform for urological and minimally invasive surgical applications.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Cellvizio is an endomicroscopy system, developed by the company, which generates optical biopsies, to provide physicians with microscopic images of tissue in a short timespan involving a minimally-invasive manner.

"Our near-infrared imaging products are designed to provide a positive impact on procedural outcomes by adding to fluorescence-guided procedures the precision and reliability of real-time cellular characterisation."

It facilitates better decision-making and appropriate patient management by means of easy pattern recognition.

Mauna Kea Technologies co-founder and CEO Sacha Loiseau said: "This FDA clearance is another step forward in expanding the utility of the Cellvizio platform in minimally invasive surgery and urological applications.

See Also:

"Our near-infrared imaging products are designed to provide a positive impact on procedural outcomes by adding to fluorescence-guided procedures the precision and reliability of real-time cellular characterisation.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"In addition to be complementary to existing intra-operative fluorescence systems that use the same near-infrared wavelength, surgical CLE data may bring physicians microscopic guidance in a wide range of surgical procedures."

The surgeons are provided an improved anatomical guidance through an image-guided surgery with intra-operative macroscopic fluorescence systems.

The near-infrared confocal miniprobes integrates with the Cellvizio platform and complements the existing macroscopic near-infrared endoscopic platforms proposed by a majority of surgical endoscopy manufacturers.

The confocal miniprobes can be operated separately by the departments GI endoscopy unit and the bronchoscopy unit which engage the Cellvizio platform, depending on their indications and needs.